Hydroxychloroquine for COVID-19: A new review of several studies shows flaws in research and no benefit

Our expert assessed all the controlled studies so far on hydroxychloroquine. His findings may surprise you.

C. Michael White, Professor and Head of the Department of Pharmacy Practice, University of Connecticut • conversation
May 28, 2020 • ~7 min

Humanizing the coronavirus as an invisible enemy is human nature

Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.

Stewart Guthrie, Professor Emeritus of Anthropology, Fordham University • conversation
May 22, 2020 • ~7 min

Fast-acting countries cut their coronavirus death rates while US delays cost thousands of lives

Over the first 100 days of the pandemic, countries that quickly implemented strong policies successfully lowered their death rates faster. There were also some surprises in the successes and failures.

Joshua Aizenman, Professor of International Relations and Economics, University of Southern California – Dornsife College of Letters, Arts and Sciences • conversation
May 22, 2020 • ~6 min

Blocking the deadly cytokine storm is a vital weapon for treating COVID-19

We blame the coronavirus for the thousands of deaths, but it is actually a hyperactive immune reaction that is the cause of death. An immunologist explains.

Alexander (Sasha) Poltorak, Professor of Immunology, Tufts University • conversation
May 20, 2020 • ~7 min

Here's how to stay safe while buying groceries amid the coronavirus pandemic

Should I wear a mask and gloves in the grocery story? Sanitize my food? A food virologist takes on the top questions people are asking as they shop for food amid the coronavirus pandemic.

Erin DiCaprio, Food virology researcher, University of California, Davis • conversation
May 19, 2020 • ~6 min

A mysterious illness is striking children amid the coronavirus pandemic – but is it Kawasaki disease?

A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.

Mark Hicar, Assistant Professor, University at Buffalo, The State University of New York • conversation
May 6, 2020 • ~7 min

A mysterious illness is striking children amid the coronavirus pandemic – but don't be too quick to tie it to Kawasaki disease

A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.

Mark Hicar, Assistant Professor, University at Buffalo, The State University of New York • conversation
May 6, 2020 • ~7 min

Remdesivir explained – what makes this drug work against viruses?

Gilead's drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?

Katherine Seley-Radtke, Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County • conversation
May 6, 2020 • ~10 min

Your genes could determine whether the coronavirus puts you in the hospital – and we're starting to unravel which ones matter

Researchers from Oregon Health and Science University found that variations in genes that code for parts of the cellular alarm system might play a role in how well people fight off COVID-19.

Reid Thompson, Assistant Professor of Radiation Medicine, Oregon Health & Science University • conversation
May 5, 2020 • ~6 min

We found and tested 47 old drugs that might treat the coronavirus: Results show promising leads and a whole new way to fight COVID-19

Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven't been tried before.

Nevan Krogan, Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco • conversation
April 30, 2020 • ~10 min

/

18